Domingo Luís Orozco Beltrán-rekin lankidetzan egindako argitalpenak (15)

2021

  1. Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study

    International Journal of Clinical Practice, Vol. 75, Núm. 1

2020

  1. The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study

    Primary Care Diabetes, Vol. 14, Núm. 6, pp. 678-684

2019

  1. Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain

    International Journal of Cardiology, Vol. 293, pp. 260-265

2018

  1. Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study (PLoS ONE (2017) 12:10 (e0186196) DOI: 10.1371/journal.pone.0186196)

    PLoS ONE

  2. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: The ESCARVAL-risk study

    BMC Cardiovascular Disorders, Vol. 18, Núm. 1

2017

  1. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Analysing the concept of diagnostic inertia in hypertension: a cross-sectional study

    International Journal of Clinical Practice, Vol. 70, Núm. 7, pp. 619-624

  2. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: The ESCARVAL-risk study

    Journal of Hypertension, Vol. 34, Núm. 6, pp. 1075-1083

  3. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors froma registry-based cohort: The Estudio Cardiovascular Valencia-risk study

    Journal of Hypertension, Vol. 34, Núm. 11, pp. 2266-2273

2014

  1. Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? cross-sectional Escarval study

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Clinical inertia in poorly controlled elderly hypertensive patients: A cross-sectional study in spanish physicians to ascertain reasons for not intensifying treatment

    American Journal of Cardiovascular Drugs, Vol. 13, Núm. 3, pp. 213-219

2011

  1. En la identificación del riesgo cardiovascular con el modelo SCORE, ¿se puede recomendar su cálculo indistintamente con colesterol total o índice aterogénico? Concordancia entre el colesterol total y el índice aterogénico en la tabla SCORE

    Revista Espanola de Cardiologia, Vol. 64, Núm. 5, pp. 421-423

  2. Is there a predictive profile for clinical inertia in hypertensive patients?: An observational, cross-sectional, multicentre study

    Drugs and Aging, Vol. 28, Núm. 12, pp. 981-992

2010

  1. Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

    BMC Public Health, Vol. 10

2007

  1. Concordancia de las escalas REGICOR y SCORE para la identificación del riesgo cardiovascular alto en la población española

    Revista Espanola de Cardiologia, Vol. 60, Núm. 10, pp. 1042-1050